跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,106 条关于
“TLB-33”
全部
3,106
临床试验
1,477
药物
440
机构
102
资讯
1,087
17小时前
Tolerance Bio Licenses Anti-IL-33 Antibody TLB-33 from Tanabe Pharma in Deal Worth Up to $560M
去年
RK-33 Eliminates Bone Metastases in Breast Cancer Models
去年
Alnylam Reports Strong 33% Growth, Sets Ambitious $2.25B Revenue Target for 2025
20天前
Cloverleaf Bio Raises $33 Million Seed Financing to Advance Engineered tRNA Cancer Therapeutics
2年前
Kisqali Shows Enhanced Efficacy in Younger Breast Cancer Patients with 33% Risk Reduction
去年
NeuroSense's PrimeC Shows 33% Reduction in ALS Disease Progression in Phase 2b Trial
去年
FDA Issues Safety Alerts for Boston Scientific Heart Devices Linked to 33 Deaths
去年
DiaCarta's Blood Test Reduces Colonoscopy Needs in CRC Screening
去年
Hong Kong Introduces Fast-Track Drug Approval System to Reduce Review Time by 33%
去年
Adagene's ADG126-Keytruda Combination Shows Promising 33% Response Rate in MSS Colorectal Cancer Trial
第 1 页,共 109 页
上一页
下一页